The effect of TCA (20%) trichloroacetic acid and topical combination of steroid and tretinoin in macular amyloidosis
Phase 3
Recruiting
- Conditions
- Macular amyloidosis.
- Registration Number
- IRCT20180102038188N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with macular amyloidosis referring to dermatology clinic of Sabzevar Vasei Hospital
Being at the age of 25 to 45 years
Satisfaction to participate in the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cutaneous pigmentation. Timepoint: 0, 1, 2 and 3 months later. Method of measurement: Checklist completed by dermatologist.
- Secondary Outcome Measures
Name Time Method -. Timepoint: -. Method of measurement: -.